"Methods Of Treating Neurodegenerative Disorders And Stat3-Linked Cancers Using Suppressors Of Electron Leak" in Patent Application Approval Process (USPTO 20240058344).
In: Cancer Weekly, 2024-03-12, S. 1734-1734
serialPeriodical
Zugriff:
A patent application has been filed for methods of treating neurodegenerative disorders and Stat3-linked cancers using suppressors of electron leak. The inventors propose using site-specific inhibitors of mitochondrial reactive oxygen species (ROS) production, known as Suppressors of Electron Leak (SELs), as a potential treatment for diseases such as Frontotemporal Dementia (FTD) and other dementias. The patent application outlines methods for administering therapeutically effective amounts of SELs to treat or prevent neurodegenerative diseases, reduce neuroinflammation or glial alteration in the brain, and treat cancer. The inventors suggest that SELs have disease-modifying properties and offer a promising approach to these conditions. [Extracted from the article]
Copyright of Cancer Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
"Methods Of Treating Neurodegenerative Disorders And Stat3-Linked Cancers Using Suppressors Of Electron Leak" in Patent Application Approval Process (USPTO 20240058344).
|
---|---|
Zeitschrift: | Cancer Weekly, 2024-03-12, S. 1734-1734 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1071-7218 (print) |
Schlagwort: |
|
Sonstiges: |
|